Detalhe da pesquisa
1.
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein.
Int J Cancer
; 139(4): 916-27, 2016 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27037627
2.
Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen.
BMC Biotechnol
; 16: 18, 2016 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26883813
3.
Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivo.
Cancer Immunol Immunother
; 64(12): 1575-86, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26472728
4.
Elimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteins.
Br J Haematol
; 183(2): 313-317, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29048126
5.
Site-specific, covalent labeling of recombinant antibody fragments via fusion to an engineered version of 6-O-alkylguanine DNA alkyltransferase.
Bioconjug Chem
; 20(5): 1010-5, 2009 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19388673
6.
Depletion of autoreactive B-lymphocytes by a recombinant myelin oligodendrocyte glycoprotein-based immunotoxin.
J Neuroimmunol
; 195(1-2): 28-35, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18280586
7.
Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells.
Biomedicines
; 6(1)2018 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29510557
8.
Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins.
PLoS One
; 12(7): e0180305, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28704435
9.
Engineered human angiogenin mutations in the placental ribonuclease inhibitor complex for anticancer therapy: Insights from enhanced sampling simulations.
Protein Sci
; 25(8): 1451-60, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27110669
10.
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
Cancer Lett
; 372(2): 201-9, 2016 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26806809
11.
Angiogenin mutants as novel effector molecules for the generation of fusion proteins with increased cytotoxic potential.
J Immunother
; 38(3): 85-95, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25710248
12.
SNAP-tag based agents for preclinical in vitro imaging in malignant diseases.
Curr Pharm Des
; 19(30): 5429-36, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23431985
13.
Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins.
J Allergy Clin Immunol
; 116(4): 910-5, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16210069